In silico veritas? Potential limitations for SARS-CoV-2 vaccine development based on T-cell epitope prediction. Silva-Arrieta S, Goulder PJR, Brander C. PLoS Pathog 2020;16:e1008607.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Silva-Arrieta S, Goulder PJR, Brander C. In silico veritas? Potential limitations for SARS-CoV-2 vaccine development based on T-cell epitope prediction. PLoS Pathog 2020;16:e1008607.
PMID: 32497149